Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner'
Portfolio Pulse from Lisa Levin
Jim Cramer, on CNBC’s 'Mad Money Lightning Round', gave his opinions on several stocks. He prefers Booking Holdings over Tripadvisor, and recommends Edwards Lifesciences over Shockwave Medical. He described Akoya Biosciences as a speculative stock and predicted a downward trend for Luminar Technologies. He supports Vitesse Energy and Stellantis, and suggested Pfizer should better utilize its funds and work more with Nurtec.
July 20, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jim Cramer prefers Booking Holdings over Tripadvisor.
Jim Cramer's positive opinion on Booking Holdings could influence investors to buy, potentially leading to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer recommends Edwards Lifesciences over Shockwave Medical.
Jim Cramer's positive opinion on Edwards Lifesciences could influence investors to buy, potentially leading to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer supports Stellantis and believes it is undervalued.
Jim Cramer's support for Stellantis and belief that it is undervalued could influence investors to buy, potentially leading to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer supports Vitesse Energy.
Jim Cramer's support for Vitesse Energy could influence investors to buy, potentially leading to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Jim Cramer suggested Pfizer should better utilize its funds and work more with Nurtec.
Jim Cramer's suggestion for Pfizer to better utilize its funds and work more with Nurtec could influence the company's future actions, but it's unclear how this will affect the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Jim Cramer described Akoya Biosciences as a speculative stock.
Jim Cramer's opinion on Akoya Biosciences as a speculative stock could influence investors to sell, potentially leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Jim Cramer predicted a downward trend for Luminar Technologies.
Jim Cramer's prediction of a downward trend for Luminar Technologies could influence investors to sell, potentially leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Jim Cramer recommends Edwards Lifesciences over Shockwave Medical.
Jim Cramer's negative opinion on Shockwave Medical could influence investors to sell, potentially leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Jim Cramer prefers Booking Holdings over Tripadvisor.
Jim Cramer's negative opinion on Tripadvisor could influence investors to sell, potentially leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80